DrugDashboards

Texaclear Pain Reliever

Caffeine, Choline salicylate · CHOLINE SALICYLATE 870 mg/30mL; CAFFEINE 65 mg/30mL · Liquid · Oral · GM Pharmaceuticals, INC

NDC 58809-0389-08 · 237 mL in 1 BOTTLE · OTC MONOGRAPH DRUG · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Opioid Analgesic REMS Shared System REMS

Regulatory

Application
M013
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Caffeine, Choline salicylate (Liquid)

LabelerStrengthFirst seenLast seen
GM Pharmaceuticals, INCCHOLINE SALICYLATE 870 mg/30mL; CAFFEINE 65 mg/30mLAug 26, 2026Sep 2, 2026
GM Pharmaceuticals, INCCHOLINE SALICYLATE 65 mg/30mL; CAFFEINE 870 mg/30mLJul 22, 2026Aug 19, 2026
GM Pharmaceuticals, INCCAFFEINE 65 mg/30mL; CHOLINE SALICYLATE 870 mg/30mLJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Texaclear Pain Reliever — NDC 58809-0389-08," retrieved September 3, 2026, https://drugdashboards.com/drug/58809038908.

Free to cite with attribution — see how the data is put together.